secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001140361-24-028800
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics shareholders elect three Class II directors and ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Steven A. Elms, Adam S. Grossman, Young T. Kwon elected as Class II directors with 71%, 97%, 98% of votes cast excluding broker non-votes.
- Ratification of CohnReznick LLP as independent auditor for FY2024 approved with 184.5M for, 2.0M against, 0.2M abstain.
- Annual meeting quorum achieved with 186.7M shares represented out of 231.8M outstanding (80.5% of shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124028800/0001140361-24-028800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124028800/ef20030555_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-028800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer